首页 > 最新文献

Evidence-Based Medicine最新文献

英文 中文
Ten essential papers for the practice of evidence-based medicine. 循证医学实践的十篇重要论文。
Pub Date : 2017-12-01 Epub Date: 2017-11-23 DOI: 10.1136/ebmed-2017-110854
David Nunan, Jack O'Sullivan, Carl Heneghan, Annette Pluddemann, Jeffrey Aronson, Kamal Mahtani

In this article we signpost readers to 10 papers we consider essential reading for anyone starting out on an evidence-based medicine journey. We have considered papers consisting a mix of old and new, seminal and cutting-edge that offer insight into what evidence-based medicine is, where it came from, why it matters and what it has achieved. This is balanced against some of the common criticisms of evidence-based medicine and efforts to tackle them. We have also highlighted papers acknowledging the importance of teaching and learning of the principles of evidence-based medicine and how health professionals can better use evidence in clinical decisions with patients.

在这篇文章中,我们为读者推荐了10篇论文,我们认为这是任何开始循证医学之旅的人必读的文章。我们考虑的论文既有旧的,也有新的,既有开创性的,也有前沿的,这些论文提供了对循证医学是什么、它从哪里来、为什么重要以及它取得了什么成就的见解。这与对循证医学的一些常见批评和解决这些批评的努力相平衡。我们还强调了承认教学和学习循证医学原则的重要性以及卫生专业人员如何更好地在患者临床决策中使用证据的论文。
{"title":"Ten essential papers for the practice of evidence-based medicine.","authors":"David Nunan,&nbsp;Jack O'Sullivan,&nbsp;Carl Heneghan,&nbsp;Annette Pluddemann,&nbsp;Jeffrey Aronson,&nbsp;Kamal Mahtani","doi":"10.1136/ebmed-2017-110854","DOIUrl":"https://doi.org/10.1136/ebmed-2017-110854","url":null,"abstract":"<p><p>In this article we signpost readers to 10 papers we consider essential reading for anyone starting out on an evidence-based medicine journey. We have considered papers consisting a mix of old and new, seminal and cutting-edge that offer insight into what evidence-based medicine is, where it came from, why it matters and what it has achieved. This is balanced against some of the common criticisms of evidence-based medicine and efforts to tackle them. We have also highlighted papers acknowledging the importance of teaching and learning of the principles of evidence-based medicine and how health professionals can better use evidence in clinical decisions with patients.</p>","PeriodicalId":12182,"journal":{"name":"Evidence-Based Medicine","volume":" ","pages":"202-204"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/ebmed-2017-110854","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35634299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Long-acting reversible contraception acceptability and satisfaction is high among adolescents. 青少年对长效可逆避孕的接受度和满意度较高。
Pub Date : 2017-12-01 Epub Date: 2017-09-18 DOI: 10.1136/ebmed-2017-110768
David Hubacher
Commentary on: Diedrich JT, Klein DA, Peipert JF, et al . Long-acting reversible contraception in adolescents: a systematic review and meta-analysis. Am J Obstet Gynecol 2017;216:364.e1-364.e12.Long-acting reversible contraception (LARC) consists of intrauterine devices and subdermal implants. LARC is in the highest tier of effectiveness and once started, most women tend to be satisfied and use it for long durations. Historically, LARC use has been concentrated in older, higher parity populations. Dissatisfaction or weariness with shorter-term contraceptives often leads women to try LARC; in addition, LARC retention (continued use) may be linked to stage of life and more resolute, long-term intentions. Thus, most of what we know about LARC effectiveness is biased by self-selection, user characteristics and needs.Women aged 15–19 are not typical LARC users; among those on contraception, 4% use LARC.1 Difficult-to-use, short-term products are the mainstay and it is …
{"title":"Long-acting reversible contraception acceptability and satisfaction is high among adolescents.","authors":"David Hubacher","doi":"10.1136/ebmed-2017-110768","DOIUrl":"https://doi.org/10.1136/ebmed-2017-110768","url":null,"abstract":"Commentary on: Diedrich JT, Klein DA, Peipert JF, et al . Long-acting reversible contraception in adolescents: a systematic review and meta-analysis. Am J Obstet Gynecol 2017;216:364.e1-364.e12.\u0000\u0000Long-acting reversible contraception (LARC) consists of intrauterine devices and subdermal implants. LARC is in the highest tier of effectiveness and once started, most women tend to be satisfied and use it for long durations. Historically, LARC use has been concentrated in older, higher parity populations. Dissatisfaction or weariness with shorter-term contraceptives often leads women to try LARC; in addition, LARC retention (continued use) may be linked to stage of life and more resolute, long-term intentions. Thus, most of what we know about LARC effectiveness is biased by self-selection, user characteristics and needs.\u0000\u0000Women aged 15–19 are not typical LARC users; among those on contraception, 4% use LARC.1 Difficult-to-use, short-term products are the mainstay and it is …","PeriodicalId":12182,"journal":{"name":"Evidence-Based Medicine","volume":" ","pages":"228-229"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/ebmed-2017-110768","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35421718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
What evidence affects clinical practice? An analysis of Evidence-Based Medicine commentaries. 什么证据影响临床实践?循证医学评论分析。
Pub Date : 2017-12-01 Epub Date: 2017-11-17 DOI: 10.1136/ebmed-2017-110856
Charles Coombs, Igho Onakpoya, Kamal Mahtani, Jeffrey Aronson, Jack O'Sullivan, Annette Pluddemann, Carl Heneghan
Evidence-Based Medicine (EBM) published by BMJ aims to alert clinicians to significant advances in healthcare by selecting original and systematic review articles, from 100 candidate journals, whose results are likely to be both reliable and useful.1 We select articles if they concern topics relevant to internal medicine, general and family practice, surgery, emergency and critical care, psychiatry, paediatrics or obstetrics and gynaecology. Articles are summarised in value-added abstracts and commented on by clinical experts in the field.To better understand the impact our choices may have on clinical practice, we audited 1 year’s worth of the journal’s commentaries, asking what journals we select from, what types of studies we choose and whether we identify articles likely to change practice.To do this, we surveyed EBM commentaries published between December 2016 and September 2017 and extracted the following information: study type, original journal, setting and type of intervention. We used the commentaries from clinical experts …
{"title":"What evidence affects clinical practice? An analysis of Evidence-Based Medicine commentaries.","authors":"Charles Coombs,&nbsp;Igho Onakpoya,&nbsp;Kamal Mahtani,&nbsp;Jeffrey Aronson,&nbsp;Jack O'Sullivan,&nbsp;Annette Pluddemann,&nbsp;Carl Heneghan","doi":"10.1136/ebmed-2017-110856","DOIUrl":"https://doi.org/10.1136/ebmed-2017-110856","url":null,"abstract":"Evidence-Based Medicine (EBM) published by BMJ aims to alert clinicians to significant advances in healthcare by selecting original and systematic review articles, from 100 candidate journals, whose results are likely to be both reliable and useful.1 We select articles if they concern topics relevant to internal medicine, general and family practice, surgery, emergency and critical care, psychiatry, paediatrics or obstetrics and gynaecology. Articles are summarised in value-added abstracts and commented on by clinical experts in the field.\u0000\u0000To better understand the impact our choices may have on clinical practice, we audited 1 year’s worth of the journal’s commentaries, asking what journals we select from, what types of studies we choose and whether we identify articles likely to change practice.\u0000\u0000To do this, we surveyed EBM commentaries published between December 2016 and September 2017 and extracted the following information: study type, original journal, setting and type of intervention. We used the commentaries from clinical experts …","PeriodicalId":12182,"journal":{"name":"Evidence-Based Medicine","volume":" ","pages":"197"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/ebmed-2017-110856","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35563793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Intensive glucose control in patients with diabetes prevents onset and progression of microalbuminuria, but effects on end-stage kidney disease are still uncertain. 糖尿病患者强化血糖控制可预防微量白蛋白尿的发生和进展,但对终末期肾病的影响仍不确定。
Pub Date : 2017-12-01 Epub Date: 2017-11-02 DOI: 10.1136/ebmed-2017-110806
Clement Lo, Sophia Zoungas
{"title":"Intensive glucose control in patients with diabetes prevents onset and progression of microalbuminuria, but effects on end-stage kidney disease are still uncertain.","authors":"Clement Lo, Sophia Zoungas","doi":"10.1136/ebmed-2017-110806","DOIUrl":"10.1136/ebmed-2017-110806","url":null,"abstract":"","PeriodicalId":12182,"journal":{"name":"Evidence-Based Medicine","volume":" ","pages":"219-220"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35219004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Routine prophylaxis is not necessary to prevent renal scarring in children with urinary tract infection. 常规预防对于预防尿路感染儿童肾脏瘢痕形成是不必要的。
Pub Date : 2017-12-01 Epub Date: 2017-10-22 DOI: 10.1136/ebmed-2017-110784
Tej K Mattoo, Ron Thomas
{"title":"Routine prophylaxis is not necessary to prevent renal scarring in children with urinary tract infection.","authors":"Tej K Mattoo, Ron Thomas","doi":"10.1136/ebmed-2017-110784","DOIUrl":"10.1136/ebmed-2017-110784","url":null,"abstract":"","PeriodicalId":12182,"journal":{"name":"Evidence-Based Medicine","volume":" ","pages":"208"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35535243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protocolised early goal-directed therapy in patients with sepsis/septic shock does not result in improved survival compared with usual care with less invasive resuscitation strategies. 在脓毒症/脓毒性休克患者中,与采用微创复苏策略的常规护理相比,协议化的早期目标导向治疗并不能提高生存率。
Pub Date : 2017-12-01 Epub Date: 2017-10-22 DOI: 10.1136/ebmed-2017-110805
Joel Meyer, Manu Shankar-Hari
{"title":"Protocolised early goal-directed therapy in patients with sepsis/septic shock does not result in improved survival compared with usual care with less invasive resuscitation strategies.","authors":"Joel Meyer, Manu Shankar-Hari","doi":"10.1136/ebmed-2017-110805","DOIUrl":"10.1136/ebmed-2017-110805","url":null,"abstract":"","PeriodicalId":12182,"journal":{"name":"Evidence-Based Medicine","volume":" ","pages":"223"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35535240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ocrelizumab appears to reduce relapse and disability in multiple sclerosis but quality of evidence is moderate. Ocrelizumab似乎可以减少多发性硬化症的复发和残疾,但证据质量是中等的。
Pub Date : 2017-12-01 Epub Date: 2017-11-08 DOI: 10.1136/ebmed-2017-110721
Graziella Filippini
{"title":"Ocrelizumab appears to reduce relapse and disability in multiple sclerosis but quality of evidence is moderate.","authors":"Graziella Filippini","doi":"10.1136/ebmed-2017-110721","DOIUrl":"10.1136/ebmed-2017-110721","url":null,"abstract":"","PeriodicalId":12182,"journal":{"name":"Evidence-Based Medicine","volume":" ","pages":"215-216"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35585233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Journal Clubs: 1. Origins. 期刊俱乐部:1;的起源。
Pub Date : 2017-12-01 Epub Date: 2017-11-17 DOI: 10.1136/ebmed-2017-110860
Jeffrey K Aronson
A journal club is a group of individuals who meet regularly to discuss publications that are relevant to their professional interests; the term is also used to describe such a meeting.The earliest mention of a journal club that I have found is in an 1854 paper by Sir John Forbes in The Association Medical Journal , which was published between 1853 and 1856, and was a forerunner of the BMJ . The Association was in financial straits, as Forbes discussed1: ‘Our dear old ASSOCIATION is in rather a bad plight; but I hope and trust she is not in any risk of death or decay, but is merely passing through a dangerous crisis, to come out of it more vivacious and more vigorous than ever.’ He was mainly concerned about the future of the journal: ‘The Association, if it exists at all, must retain …
{"title":"Journal Clubs: 1. Origins.","authors":"Jeffrey K Aronson","doi":"10.1136/ebmed-2017-110860","DOIUrl":"https://doi.org/10.1136/ebmed-2017-110860","url":null,"abstract":"A journal club is a group of individuals who meet regularly to discuss publications that are relevant to their professional interests; the term is also used to describe such a meeting.\u0000\u0000The earliest mention of a journal club that I have found is in an 1854 paper by Sir John Forbes in The Association Medical Journal , which was published between 1853 and 1856, and was a forerunner of the BMJ . The Association was in financial straits, as Forbes discussed1: ‘Our dear old ASSOCIATION is in rather a bad plight; but I hope and trust she is not in any risk of death or decay, but is merely passing through a dangerous crisis, to come out of it more vivacious and more vigorous than ever.’ He was mainly concerned about the future of the journal: ‘The Association, if it exists at all, must retain …","PeriodicalId":12182,"journal":{"name":"Evidence-Based Medicine","volume":" ","pages":"231"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/ebmed-2017-110860","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35563794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Supplementary antimicrobials for patients with HIV and <100 CD4 cells/µL are associated with improved survival. 对艾滋病毒感染者和<100 CD4细胞/µL的患者补充抗菌素可提高生存率。
Pub Date : 2017-12-01 Epub Date: 2017-11-13 DOI: 10.1136/ebmed-2017-110843
George W Rutherford, Elvin Geng
{"title":"Supplementary antimicrobials for patients with HIV and <100 CD4 cells/µL are associated with improved survival.","authors":"George W Rutherford, Elvin Geng","doi":"10.1136/ebmed-2017-110843","DOIUrl":"10.1136/ebmed-2017-110843","url":null,"abstract":"","PeriodicalId":12182,"journal":{"name":"Evidence-Based Medicine","volume":" ","pages":"209"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35549107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What data sources do ophthalmologists trust? 眼科医生信任哪些数据来源?
Pub Date : 2017-12-01 Epub Date: 2017-10-17 DOI: 10.1136/ebmed-2017-110757
William C Stewart, Jeanette A Stewart, Lindsay A Nelson

To survey ophthalmologists regarding sources they trust when incorporating new medical knowledge into their practice. The survey was distributed primarily to US-based ophthalmologists. Questions were derived based on the lead author's research experience from congresses and discussions and from mentions in the medical literature. In total, 77 physicians completed the survey of 1886 sent (4% response rate). Regarding study design, physicians preferred a well-controlled, randomised, double-masked trial (99%) with multicentred investigational site across a wide geographical area (80%). Authorship of a research article was most desired from a well-known key opinion leader (KOL) (75%) or any KOL leader at a university (75%). The most selected journal type was a subspecialty publication (86%) and second a multispecialty high impact journal (77%). Study sponsorship was most desired from the NIH or other government agencies (71%) or a university (71%). Doctors preferred clinical opinions from an ophthalmic medical society (75%). For the source of new clinical data, physicians indicated an unsponsored peer-reviewed journal article (77%) or a lecture at a large ophthalmic congress (74%) as the preferred source. Ophthalmologists generally desire sponsors, study designs and opinions that appear free of bias on which to base their clinical practice decisions.

调查眼科医生在将新的医学知识纳入其实践时所信任的来源。该调查主要分发给美国眼科医生。这些问题是根据主要作者在大会和讨论中的研究经验以及医学文献中的提及得出的。共77名医生完成了1886份问卷调查,回复率为4%。在研究设计方面,医生更喜欢控制良好、随机、双掩模试验(99%),在广泛的地理区域进行多中心研究(80%)。最希望知名的关键意见领袖(KOL)(75%)或大学的任何KOL领袖(75%)撰写一篇研究文章。选择最多的期刊类型是亚专业期刊(86%),其次是多专业高影响力期刊(77%)。研究赞助最希望来自国立卫生研究院或其他政府机构(71%)或大学(71%)。医生更喜欢来自眼科医学协会的临床意见(75%)。对于新临床数据的来源,医生们认为非赞助的同行评议期刊文章(77%)或大型眼科会议的讲座(74%)是首选来源。眼科医生通常希望赞助商、研究设计和意见看起来没有偏见,以此作为临床实践决策的基础。
{"title":"What data sources do ophthalmologists trust?","authors":"William C Stewart,&nbsp;Jeanette A Stewart,&nbsp;Lindsay A Nelson","doi":"10.1136/ebmed-2017-110757","DOIUrl":"https://doi.org/10.1136/ebmed-2017-110757","url":null,"abstract":"<p><p>To survey ophthalmologists regarding sources they trust when incorporating new medical knowledge into their practice. The survey was distributed primarily to US-based ophthalmologists. Questions were derived based on the lead author's research experience from congresses and discussions and from mentions in the medical literature. In total, 77 physicians completed the survey of 1886 sent (4% response rate). Regarding study design, physicians preferred a well-controlled, randomised, double-masked trial (99%) with multicentred investigational site across a wide geographical area (80%). Authorship of a research article was most desired from a well-known key opinion leader (KOL) (75%) or any KOL leader at a university (75%). The most selected journal type was a subspecialty publication (86%) and second a multispecialty high impact journal (77%). Study sponsorship was most desired from the NIH or other government agencies (71%) or a university (71%). Doctors preferred clinical opinions from an ophthalmic medical society (75%). For the source of new clinical data, physicians indicated an unsponsored peer-reviewed journal article (77%) or a lecture at a large ophthalmic congress (74%) as the preferred source. Ophthalmologists generally desire sponsors, study designs and opinions that appear free of bias on which to base their clinical practice decisions.</p>","PeriodicalId":12182,"journal":{"name":"Evidence-Based Medicine","volume":" ","pages":"205-207"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/ebmed-2017-110757","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35523612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Evidence-Based Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1